Clinical trial

Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities

NCT02751307

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-05-01

PhasePHASE4

Study timeline

Study start (unknown)2013-05-01Date precision: month

Registry last updated2016-04-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metabolic Syndromeunresolved

Interventions

metformin 500 mgDRUG

clozapine 100 mgDRUG · verified · RxNorm: clozapine 100 MG

Sponsors & collaborators

Taipei Medical University WanFang Hospitallead sponsor

Taipei City Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02751307 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.